CD8A and ovarian cancer: Here, using a depleting antibody-based strategy, we demonstrated that the synergistic effect of combination treatment depended on both CD8+ T cells and B cells (Figure 8B-D), suggesting an antitumor role for infiltrated B cells in the ID8 model, which is in accordance with previous reports in ovarian cancer 40,47.